Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|January 23, 1988
Placebo-controlled trial of topical interferon in labial and genital herpesM Glezerman, E Lunenfeld, V Cohen, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Maternal plasma and amniotic fluid 17 beta-estradiol, progesterone and cortisol concentrations in women with successfully and unsuccessfully treated preterm laborM Mazor, R Hershkowitz, F Ghezzi, et al.
Human Reproduction (Oxford, England)|May 1, 1995
Endogenous plasma growth hormone and the occurrence of pregnancies in patients undergoing in-vitro fertilization and embryo transfer with ovarian stimulationG Potashnik, E Lunenfeld, I Shwartz, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Maternal plasma and amniotic fluid dehydroepiandrosterone-sulfate concentrations in preterm labor and deliveryM Mazor, F Ghezzi, J Cohen, et al.
Clinical Endocrinology|October 1, 1983
Inhibition of 3-beta-hydroxy steroid dehydrogenase activity in first trimester human pregnancy with trilostane and WIN 32729Z M van der Spuy, D L Jones, C S Wright, et al.
Archives of Gynecology and Obstetrics|January 1, 1996
Prolactin concentrations in preterm and term pregnancy and labourM Mazor, R Hershkowitz, F Ghezzi, et al.
International Journal of Oncology|May 15, 2001
Expression of heparanase, Mdm2, and erbB2 in ovarian cancerS Ginath, J Menczer, Y Friedmann, et al.
Human Reproduction (Oxford, England)|November 1, 1992
The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transferG Potashnik, E Lunenfeld, E Levitas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2009
A multicenter validation of computerized tomography models as predictors of non- optimal primary cytoreduction of advanced epithelial ovarian cancerO Gemer, M Gdalevich, M Ravid, et al.
Gynecologic Oncology|September 28, 2000
Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations statusA Fishman, E Dekel, A Chetrit, et al.
Pageof 22